Xi Guo

1.4k total citations · 1 hit paper
53 papers, 806 citations indexed

About

Xi Guo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Xi Guo has authored 53 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Xi Guo's work include Sarcoma Diagnosis and Treatment (12 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Cancer Genomics and Diagnostics (6 papers). Xi Guo is often cited by papers focused on Sarcoma Diagnosis and Treatment (12 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Cancer Genomics and Diagnostics (6 papers). Xi Guo collaborates with scholars based in China, United States and Saint Kitts and Nevis. Xi Guo's co-authors include Xiongbing Zu, Jinbo Chen, Peihua Liu, Huihuang Li, Jiao Hu, Huihui Zhang, Dongxu Qiu, Wenbiao Ren, Guanghui Gong and Rongyuan Zhuang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xi Guo

50 papers receiving 801 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer

2021 250 citations Peihua Liu, Xi Guo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xi Guo China	14	307	278	259	213	152	53	806
Sara Orecchia Italy	17	390 1.3×	285 1.0×	445 1.7×	134 0.6×	129 0.8×	37	1.1k
Pengyu Chang China	16	316 1.0×	257 0.9×	210 0.8×	119 0.6×	117 0.8×	34	844
Zhiyong He China	19	403 1.3×	408 1.5×	337 1.3×	159 0.7×	184 1.2×	48	1.2k
Lijie Chen China	18	484 1.6×	259 0.9×	291 1.1×	255 1.2×	64 0.4×	49	1.0k
Minhui Zhu China	16	230 0.7×	131 0.5×	155 0.6×	174 0.8×	98 0.6×	62	681
Liang Shang China	17	685 2.2×	212 0.8×	227 0.9×	425 2.0×	137 0.9×	64	1.1k
Jia Huang China	20	457 1.5×	169 0.6×	98 0.4×	158 0.7×	123 0.8×	52	1.4k
Young Jae Moon South Korea	17	370 1.2×	363 1.3×	190 0.7×	99 0.5×	112 0.7×	45	927
Guowei Zhang China	15	432 1.4×	159 0.6×	117 0.5×	186 0.9×	119 0.8×	39	825
Jonathan C. M. Clark Australia	14	488 1.6×	217 0.8×	294 1.1×	300 1.4×	117 0.8×	18	957

Countries citing papers authored by Xi Guo

Since Specialization

Citations

This map shows the geographic impact of Xi Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Guo more than expected).

Fields of papers citing papers by Xi Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Guo. The network helps show where Xi Guo may publish in the future.

Co-authorship network of co-authors of Xi Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Guo. A scholar is included among the top collaborators of Xi Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Guo. Xi Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yuquan, Xi Guo, Weina Yang, et al.. (2025). Retrospective comparative study on efficacy and safety of different surgical procedures for pelvic organ prolapse. Scientific Reports. 15(1). 21153–21153. 1 indexed citations

Zhao, Yingying, Jiali Qian, Hanxing Tong, et al.. (2024). TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway. Cellular Oncology. 48(2). 455–470. 1 indexed citations

Liang, Li, Xiao Wang, Yang You, et al.. (2024). Identification of Novel Tumor Pyroptosis-Related Antigens and Pyroptosis Subtypes for Developing mRNA Vaccines in Pancreatic Adenocarcinoma. Biomedicines. 12(4). 726–726. 4 indexed citations

Wang, Wei, Chenyang Li, Zhaoxi Chen, et al.. (2024). Detection of Sleep Apnea-Hypopnea Events Using Millimeter-wave Radar and Pulse Oximeter. PubMed. 2024. 1–5. 3 indexed citations

Wu, Lili, Yaolin Xu, Yuhong Zhou, et al.. (2023). Additional adjuvant radiotherapy improves survival at 1 year after surgical treatment for pancreatic cancer patients with T4, N2 disease, positive resection margin, and receiving adjuvant chemotherapy. Frontiers in Oncology. 13. 1 indexed citations

Zhang, Chenlu, Wenshuai Liu, Na Zhu, et al.. (2023). Case report: Pathological complete response to perioperative treatment of radiotherapy combined with angiogenesis inhibitor in a patient with pleomorphic liposarcoma. Frontiers in Oncology. 13. 925233–925233. 2 indexed citations

Zhou, Wencheng, Xi Guo, Rui Zhong, et al.. (2022). Poly(&epsiv;-Caprolactone)-Methoxypolyethylene Glycol (PCL-MPEG)-Based Micelles for Drug-Delivery: The Effect of PCL Chain Length on Blood Components, Phagocytosis, and Biodistribution. Dove Medical Press (Taylor and Francis Group). 13 indexed citations

Chen, Yanjie, Weifeng Hong, Xi Guo, et al.. (2022). An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis. Cell Death and Disease. 13(3). 237–237. 30 indexed citations

Zhuang, Rongyuan, Xi Guo, Yang You, et al.. (2022). Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial. Clinical Cancer Research. 28(24). 5290–5296. 11 indexed citations

10.

Wu, Jing, Yang You, Rongyuan Zhuang, et al.. (2022). Twenty-eight months progression-free survival after pyrotinib therapy for HER2-positive recurrent ovarian clear cell carcinoma: a case report. Annals of Translational Medicine. 10(6). 387–387. 3 indexed citations

11.

Li, Wei, Yueqi Wang, Qian Li, et al.. (2022). Toripalimab in advanced biliary tract cancer. The Innovation. 3(4). 100255–100255. 12 indexed citations

12.

Zhang, Chenlu, Zhiming Wang, Rongyuan Zhuang, et al.. (2020). <p>Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing</p>. OncoTargets and Therapy. Volume 13. 10335–10342. 10 indexed citations

13.

Wu, Lili, Yuhong Zhou, Yue Fan, et al.. (2020). Consolidative Chemoradiotherapy After Induced Chemotherapy Is an Optimal Regimen for Locally Advanced Pancreatic Cancer. Frontiers in Oncology. 9. 1543–1543. 3 indexed citations

14.

Liu, Peihua, Xiaozhou Li, Xi Guo, et al.. (2019). Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa‐miR‐132‐3p/Sox5 signalling pathway. Cell Proliferation. 52(4). e12614–e12614. 67 indexed citations

15.

Guo, Xi, Hong Sun, Jihong Dong, et al.. (2019). Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 139. 16–23. 26 indexed citations

16.

Duan, Zhongxin, Hao Li, Xin Qi, et al.. (2019). Crocin attenuation of neurological deficits in a mouse model of intracerebral hemorrhage. Brain Research Bulletin. 150. 186–195. 11 indexed citations

17.

Xu, Yaolin, Xi Guo, Yue Fan, et al.. (2018). Efficacy and safety comparison of nabpaclitaxel plus S-1 and gemcitabine plus S-1 as first-line chemotherapy for metastatic pancreatic cancer. Japanese Journal of Clinical Oncology. 48(6). 535–541. 7 indexed citations

18.

Guo, Xi, Lu Ma, Xin Qi, et al.. (2018). Rat Brainstem Hemorrhage Model: Key Points to Success in Modeling. World Neurosurgery. 117. e106–e116. 7 indexed citations

19.

Ying, Ying, et al.. (2017). An Exploration of the Impact of Anticentromere Antibody on Early-Stage Embryo. Journal of Immunology Research. 2017. 1–4. 2 indexed citations

20.

Zhuang, Rongyuan, Song Li, Qian Li, et al.. (2017). The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis. PLoS ONE. 12(8). e0182562–e0182562. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact